sur New To The Street
New Visionaries Series Episode Spotlights Acurx Pharmaceuticals on Bloomberg
The much-anticipated Visionaries Series, a collaboration between New to The Street and Sight & Sound, launches tomorrow at 6:30 PM EST on Bloomberg. The episode, featuring Acurx Pharmaceuticals, follows the impressive journey of its co-founders: David P. Luci, Robert J. DeLuccia, and Robert G. Shawah. This installment delves into their path from college days to the establishment of groundbreaking pharmaceutical companies, culminating in the creation of Acurx Pharmaceuticals.
The series sheds light on their determination and expertise, which have been pivotal in developing antibiotics that address significant global health issues. Acurx’s lead product candidate, ibezapolstat, is poised for international Phase 3 clinical trials, targeting C. difficile infections, and the company is also progressing with new treatments for ABSSSI and inhaled anthrax.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de New To The Street